Access the full text.
Sign up today, get DeepDyve free for 14 days.
H. Yoshioka, Y. Katsume, H. Akune (1981)
Experimental Central Serous Chorioretinopathy-1-Clinical FindingsJapanese Journal of Ophthalmology, 25
P. Scarpace, L. Baresi, J. Morley (1988)
Glucocorticoids modulate beta-adrenoceptor subtypes and adenylate cyclase in brown fat.The American journal of physiology, 255 2 Pt 1
M. Tittl, R. Spaide, D. Wong, E. Pilotto, L. Yannuzzi, Y. Fisher, B. Freund, D. Guyer, J. Slakter, J. Sorenson (1999)
Systemic findings associated with central serous chorioretinopathy.American journal of ophthalmology, 128 1
H. Yoshioka, T. Sugita, K. Nagayoshi (1970)
[Fluorescein angiographic findings in experimental retinopathy produced by intravenous adrenaline injection. Preliminary report].Nihon ganka kiyo, 21 9
H. Yoshioka, Y. Katsume, H. Akune, H. Nagasaki (1984)
Experimental Central Serous ChorioretinopathyThe Kurume Medical Journal, 31
M. Sakaue, B. Hoffman (1991)
Glucocorticoids induce transcription and expression of the alpha 1B adrenergic receptor gene in DTT1 MF-2 smooth muscle cells.The Journal of clinical investigation, 88 2
(1970)
Fluorescein angiography findings in experimental retinopathy produced by intravenous adrenaline injection
M. Wakakura, S. Ishikawa (1984)
Central serous chorioretinopathy complicating systemic corticosteroid treatment.British Journal of Ophthalmology, 68
J. Gass (1973)
Bullous retinal detachment. An unusual manifestation of idiopathic central serous choroidopathy.American journal of ophthalmology, 75 5
K. Nagayoshi (1971)
[Experimental study of choroidoretinopathy by intravenous injection of adrenaline].Nippon Ganka Gakkai zasshi, 75 8
(1981)
Experi - mental central serous chorioretinopathy . I . Clinical findings
D. Quillen, J. Gass, R. Brod, T. Gardner, G. Blankenship, J. Gottlieb (1996)
Central serous chorioretinopathy in women.Ophthalmology, 103 1
B. Polak, G. Baarsma, B. Snyers, C. Polak (1995)
Diffuse retinal pigment epitheliopathy complicating systemic corticosteroid treatment.British Journal of Ophthalmology, 79
E. Bouzas, P. Karadimas, C. Pournaras (2002)
Central serous chorioretinopathy and glucocorticoids.Survey of ophthalmology, 47 5
M. Klein, M. Klein, E. Buskirk, E. Friedman, E. Gragoudas, S. Chandra (1974)
Experience with nontreatment of central serous choroidopathy.Archives of ophthalmology, 91 4
T. Miki, I. Sunada, T. Higaki (1972)
[Studies on chorioretinitis induced in rabbits by stress (repeated administration of epinephrine)].Nippon Ganka Gakkai zasshi, 76 9
J. Gass, H. Little (1995)
Bilateral bullous exudative retinal detachment complicating idiopathic central serous chorioretinopathy during systemic corticosteroid therapy.Ophthalmology, 102 5
Richard Levine, A. Brucker, Fane Robinson (1989)
Long-term follow-up of idiopathic central serous chorioretinopathy by fluorescein angiography.Ophthalmology, 96 6
(1996)
Indocyanine green videoangiography of central serous chorioretinopathy in older adults
C. Carvalho-Recchia, L. Yannuzzi, S. Negrão, R. Spaide, K. Freund, H. Rodriguez-Coleman, Marcio Lenharo, T. Iida (2002)
Corticosteroids and central serous chorioretinopathy.Ophthalmology, 109 10
Patricia Smith (1984)
Long-term follow-up of central serous chorioretinopathy.British Journal of Ophthalmology, 68
(2002)
tral serous chorioretinopathy and glucocorticoids
R. Haimovici, R. Haimovici, E. Gragoudas, Jay Duker, R. Sjaarda, Dean Eliott (1997)
Central serous chorioretinopathy associated with inhaled or intranasal corticosteroids.Ophthalmology, 104 10
M. Wakakura, E. Song, S. Ishikawa (1997)
Corticosteroid-induced central serous chorioretinopathy.Japanese journal of ophthalmology, 41 3
H. Yoshioka, Y. Katsume, H. Akune (1982)
Experimental central serous chorioretinopathy in monkey eyes: fluorescein angiographic findings.Ophthalmologica. Journal international d'ophtalmologie. International journal of ophthalmology. Zeitschrift fur Augenheilkunde, 185 3
Purpose: To determine the relationship between the clinical characteristics of patients with central serous chorioretinopathy (CSC) and systemic corticosteroid therapy. Methods: The medical records of 17 cases of CSC that developed during systemic corticosteroid treatment from 1987 to 1999 at Chiba University Hospital were reviewed. The relationship of CSC to the age, gender, laterality, and disease requiring the corticosteroid treatment, and the dose and duration of corticosteroid therapy were examined. Results: There were 6 men and 11 women, and 2 of these developed bilateral and 15 developed unilateral CSC. The duration from the beginning of corticosteroid treatment to the onset of CSC ranged from 3 days to 23 years; 9 patients developed CSC within 1 year after the beginning of the corticosteroid medication and 6 patients after more than 8 years. The amount of corticosteroid medication at the onset of CSC ranged from 5 to 1,000 mg/day equivalent prednisolone units. There was a significant correlation between age at the onset of CSC and the daily dosage of corticosteroid. Conclusion: Even small amounts of daily corticosteroids (5–10 mg/day) can cause CSC, especially in elderly patients. These findings indicate that we need to monitor patients undergoing corticosteroid treatment carefully.
Ophthalmologica – Karger
Published: Apr 1, 2004
Keywords: Retinal pigment epithelium; Adrenaline; Age; Idiopathic central serous chorioretinopathy; Corticosteroid
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.